The three institutions are members of the New England Clinical and Translational Research Network, which was established five years ago. The funding will go toward efforts to address chronic and life-threatening diseases in the elderly, New American and Indigenous populations.
“We are optimistic that this grant will provide the resources necessary to make chronic and life-threatening diseases preventable and curable,” said Gary Stein, PhD, NNE-CTR principle investigator and UVM chair of biochemistry. “The program will capture immense opportunities available through the emerging power of precision/genomic medicine, and coupled with our important partnership with the Vermont Department of Health, we are poised to meet the obligation of responding to disparities encountered by our underserved populations.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
